Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2011

01-07-2011 | Original Article

miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42

Authors: Qingjiang Chen, Xiaobing Chen, Mingzhi Zhang, Qingxia Fan, Suxia Luo, Xinguang Cao

Published in: Digestive Diseases and Sciences | Issue 7/2011

Login to get access

Abstract

Introduction

MicroRNAs (miRNAs) are a class of small (19–25 nucleotides) noncoding RNAs that regulate the expressions of a wide variety of genes, including some involved in cancer development. Some recent studies show that DNA methylation contributes to down-regulation of microRNA-137 (miR-137) during tumorigenesis. Whether down-regulation of miR-137 also exists in gastric cancer is unknown.

Aim

Our aim was to test the hypothesis that down-regulation of miR-137 also exists in gastric cancer.

Methods

Expression of levels of miR-137 were examined using real-time PCR on paired gastric cancer and adjacent non-cancerous tissues. The methylation status is detected by MSP.

Results

Results show that miR-137 is downregulated by hypermethylation of the promoter in gastric cancer tissues. Epigenetic silencing of miR-137 induced an up-regulation of its targets, Cdc42. Restoration of the miR-137 expression in gastric cancer cell lines downregulated the Cdc42 expression. Restoration of the miR-137 and inactivation of Cdc42 induce apoptosis and cell cycle G1 arrest in gastric cancer cells. Furthermore, the miR-137 expression was found to be inversely correlated with CDC42 expression in gastric caner.

Conclusions

miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12.PubMedCrossRef Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12.PubMedCrossRef
2.
go back to reference Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563–568.PubMedCrossRef Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563–568.PubMedCrossRef
3.
go back to reference Huang YW, Liu JC, Deatherage DE, et al. Epigenetic repression of microRNA-129–2 leads to overexpression of sox4 oncogene in endometrial cancer. Cancer Res. 2009;69:9038–9046.PubMedCrossRef Huang YW, Liu JC, Deatherage DE, et al. Epigenetic repression of microRNA-129–2 leads to overexpression of sox4 oncogene in endometrial cancer. Cancer Res. 2009;69:9038–9046.PubMedCrossRef
4.
go back to reference Dyrskjot L, Ostenfeld MS, Bramsen JB, et al. Genomic profiling of microRNAs in bladder cancer: Mir-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009;69:4851–4860.PubMedCrossRef Dyrskjot L, Ostenfeld MS, Bramsen JB, et al. Genomic profiling of microRNAs in bladder cancer: Mir-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009;69:4851–4860.PubMedCrossRef
5.
go back to reference Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68:2094–2105.PubMedCrossRef Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68:2094–2105.PubMedCrossRef
6.
go back to reference Silber J, Lim DA, Petritsch C, et al. Mir-124 and mir-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.PubMedCrossRef Silber J, Lim DA, Petritsch C, et al. Mir-124 and mir-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.PubMedCrossRef
7.
go back to reference Bemis LT, Chen R, Amato CM, et al. Microrna-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 2008;68:1362–1368.PubMedCrossRef Bemis LT, Chen R, Amato CM, et al. Microrna-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 2008;68:1362–1368.PubMedCrossRef
8.
go back to reference Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q, Chen J, Chen X, Zhang S, Liu Z, Zhou J, Zhu Y, Deng Y, Zheng Y, Bi F. Mir-137 targets cdc42 expression, induces cell cycle g1 arrest, and inhibits invasion in colorectal cancer cells. Accepted in Int J Cancer. Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q, Chen J, Chen X, Zhang S, Liu Z, Zhou J, Zhu Y, Deng Y, Zheng Y, Bi F. Mir-137 targets cdc42 expression, induces cell cycle g1 arrest, and inhibits invasion in colorectal cancer cells. Accepted in Int J Cancer.
9.
go back to reference Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A. Epigenetic silencing of mir-137 is an early event in colorectal carcinogenesis. Cancer Res. 2010;70:6609–6618.PubMedCrossRef Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A. Epigenetic silencing of mir-137 is an early event in colorectal carcinogenesis. Cancer Res. 2010;70:6609–6618.PubMedCrossRef
10.
go back to reference Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E. Microrna-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis. 2010;31:864–870.PubMedCrossRef Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E. Microrna-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis. 2010;31:864–870.PubMedCrossRef
11.
go back to reference Szczur K, Zheng Y, Filippi MD. The small Rho GTPase Cdc42 regulates neutrophil polarity via CD11b integrin signaling. Blood. 2009;114:4527–4537.PubMedCrossRef Szczur K, Zheng Y, Filippi MD. The small Rho GTPase Cdc42 regulates neutrophil polarity via CD11b integrin signaling. Blood. 2009;114:4527–4537.PubMedCrossRef
12.
go back to reference Feng Y, Hartig SM, Bechill JE, Blanchard EG, Caudell E, Corey SJ. The cdc42-interacting protein-4 (cip4) gene knock-out mouse reveals delayed and decreased endocytosis. J Biol Chem. 2010;285:4348–4354.PubMedCrossRef Feng Y, Hartig SM, Bechill JE, Blanchard EG, Caudell E, Corey SJ. The cdc42-interacting protein-4 (cip4) gene knock-out mouse reveals delayed and decreased endocytosis. J Biol Chem. 2010;285:4348–4354.PubMedCrossRef
13.
go back to reference Gomez Del Pulgar T, Valdes-Mora F, Bandres E, et al. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int J Oncol. 2008;33:185–193.PubMed Gomez Del Pulgar T, Valdes-Mora F, Bandres E, et al. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int J Oncol. 2008;33:185–193.PubMed
15.
go back to reference Kamai T, Yamanishi T, Shirataki H, et al. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res. 2004;10:4799–4805.PubMedCrossRef Kamai T, Yamanishi T, Shirataki H, et al. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res. 2004;10:4799–4805.PubMedCrossRef
16.
go back to reference Yang L, Wang L, Zheng Y. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol Biol Cell. 2006;17:4675–4685.PubMedCrossRef Yang L, Wang L, Zheng Y. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol Biol Cell. 2006;17:4675–4685.PubMedCrossRef
17.
go back to reference Zugasti O, Rul W, Roux P, et al. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol. 2001;21:6706–6717.PubMedCrossRef Zugasti O, Rul W, Roux P, et al. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol Cell Biol. 2001;21:6706–6717.PubMedCrossRef
Metadata
Title
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
Authors
Qingjiang Chen
Xiaobing Chen
Mingzhi Zhang
Qingxia Fan
Suxia Luo
Xinguang Cao
Publication date
01-07-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1536-3

Other articles of this Issue 7/2011

Digestive Diseases and Sciences 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.